The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Amidoxime     N-[amino-[4-[5-[4-(amino- nitroso...

Synonyms: AC1LACP0, CHEMBL321317
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Amidoxime

 

High impact information on Amidoxime

 

Biological context of Amidoxime

  • Conversion of the nitrile to the amidoxime and acylation with a range of acid chlorides in parallel followed by treatment with TBAF under ambient conditions afforded a library of 3,5-disubstituted 1,2,4-oxadiazoles [10].
 

Associations of Amidoxime with other chemical compounds

 

Gene context of Amidoxime

 

Analytical, diagnostic and therapeutic context of Amidoxime

  • Application of this principle to the structurally related amidino carboxylate 13 led to the amidoxime ester 18 which was absorbed approximately 20 times better, after oral administration to mice, than 13 [13].
  • The presence of the two amidoxime peaks in chromatograms was confirmed by liquid secondary ion mass spectrometry and by unequivocal synthesis of the suspected metabolites [14].
  • The protective effect of O-(3-piperidino-2-hydroxy-1-propyl)nicotinic amidoxime (BGP-15) against ischemia-reperfusion-induced injury was studied in the Langendorff heart perfusion system [2].

References

  1. Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance. Lanteri, C.A., Stewart, M.L., Brock, J.M., Alibu, V.P., Meshnick, S.R., Tidwell, R.R., Barrett, M.P. Mol. Pharmacol. (2006) [Pubmed]
  2. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase. Szabados, E., Literati-Nagy, P., Farkas, B., Sumegi, B. Biochem. Pharmacol. (2000) [Pubmed]
  3. In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis. Ansede, J.H., Voyksner, R.D., Ismail, M.A., Boykin, D.W., Tidwell, R.R., Hall, J.E. Xenobiotica (2005) [Pubmed]
  4. Influence of BGP-15, a nicotinic amidoxime derivative, on the vascularization and growth of murine hepatoma xenografts. Kardon, T., Nagy, G., Csala, M., Kiss, A., Schaff, Z., Nagy, P.L., Wunderlich, L., Bánhegyi, G., Mandl, J. Anticancer Res. (2006) [Pubmed]
  5. Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor. Farkas, B., Magyarlaki, M., Csete, B., Nemeth, J., Rabloczky, G., Bernath, S., Literáti Nagy, P., Sümegi, B. Biochem. Pharmacol. (2002) [Pubmed]
  6. Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase. Saulter, J.Y., Kurian, J.R., Trepanier, L.A., Tidwell, R.R., Bridges, A.S., Boykin, D.W., Stephens, C.E., Anbazhagan, M., Hall, J.E. Drug Metab. Dispos. (2005) [Pubmed]
  7. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid). Clement, B., Mau, S., Deters, S., Havemeyer, A. Drug Metab. Dispos. (2005) [Pubmed]
  8. Characterization of in vitro biotransformation of new, orally active, direct thrombin inhibitor ximelagatran, an amidoxime and ester prodrug. Clement, B., Lopian, K. Drug Metab. Dispos. (2003) [Pubmed]
  9. Design and synthesis of factor Xa inhibitors and their prodrugs. Song, Y., Clizbe, L., Bhakta, C., Teng, W., Wong, P., Huang, B., Tran, K., Sinha, U., Park, G., Reed, A., Scarborough, R.M., Zhu, B.Y. Bioorg. Med. Chem. Lett. (2003) [Pubmed]
  10. An improved synthesis of 1,2,4-oxadiazoles on solid support. Rice, K.D., Nuss, J.M. Bioorg. Med. Chem. Lett. (2001) [Pubmed]
  11. Synthesis of anthelmintically active N-methylated amidoxime analogues of the cyclic octadepsipeptide PF1022A. Jeschke, P., Harder, A., von Samson-Himmelstjerna, G., Etzel, W., Gau, W., Thielking, G., Bonse, G. Pest Manag. Sci. (2002) [Pubmed]
  12. Potential acetylcholinesterase reactivators: oxime and amidoxime derivatives. Serafin, B., Majewski, M., Kleinrok, Z., Jagiełło-Wojtowicz, E., Rajtar, G., Sieklucka-Dziuba, M., Kolasa, K. Arch. Immunol. Ther. Exp. (Warsz.) (1976) [Pubmed]
  13. Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines. Weller, T., Alig, L., Beresini, M., Blackburn, B., Bunting, S., Hadváry, P., Müller, M.H., Knopp, D., Levet-Trafit, B., Lipari, M.T., Modi, N.B., Müller, M., Refino, C.J., Schmitt, M., Schönholzer, P., Weiss, S., Steiner, B. J. Med. Chem. (1996) [Pubmed]
  14. Metabolic N-hydroxylation of pentamidine in vitro. Berger, B.J., Lombardy, R.J., Marbury, G.D., Bell, C.A., Dykstra, C.C., Hall, J.E., Tidwell, R.R. Antimicrob. Agents Chemother. (1990) [Pubmed]
 
WikiGenes - Universities